Also known as amyloid beta 40, β-amyloid (1-40), Aβ40, and Aβ(1-40).
PrevenTRON Phase III enrollment has started; Phase II TARBELA-AD launched for oral NLRP3 inhibitor RG6434; Brainshuttle trontinemab shows rapid amyloid removal; new Elecsys pTau217/pTau181 data published.